Blue Matter will be sponsoring the 2026 LSX Congress USA, which will take place in Boston, Sept. 23-24.  In addition, Pankaj Oza, Managing Partner at Blue Matter, will be moderating a panel discussion there:

Panel:

Commercializing Rare Disease Therapies: Challenges and Opportunities

  • Navigating limited patient populations and high development costs
  • Building awareness and education among healthcare providers
  • Leveraging orphan drug incentives and regulatory support

1:30 pm, Wednesday, September 23, 2026

Panelists:

  • Pankaj Oza, Managing Partner, Blue Matter (Moderator)
  • Jennifer Schranz, SVP Global Head of Rare Diseases, Ipsen
  • Julie Carnis, VP, US Head of Rare Oncology, SERB Pharmaceuticals
  • Christine Mikail, President, CFO, & Board Director, Neurogene
  • Other panelists TBD

 

 

Learn More